To investigate these alternative mechanisms, we analyzed mRNA from OPG- and control shRNA-treated cells using a quantitative reverse transcription PCR (qRT-PCR) array focused on genes involved in breast cancer. The gene discussed is TNFRSF11B; the disease is breast carcinoma.